BE880220A - 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries - Google Patents

1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries

Info

Publication number
BE880220A
BE880220A BE1/9621A BE1009621A BE880220A BE 880220 A BE880220 A BE 880220A BE 1/9621 A BE1/9621 A BE 1/9621A BE 1009621 A BE1009621 A BE 1009621A BE 880220 A BE880220 A BE 880220A
Authority
BE
Belgium
Prior art keywords
arylpiperidines
tetra
alkyl
preparation
therapeutic use
Prior art date
Application number
BE1/9621A
Other languages
English (en)
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE880220A publication Critical patent/BE880220A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
BE1/9621A 1978-11-29 1979-11-23 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries BE880220A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/965,137 US4284635A (en) 1978-11-29 1978-11-29 Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines

Publications (1)

Publication Number Publication Date
BE880220A true BE880220A (fr) 1980-05-23

Family

ID=25509504

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9621A BE880220A (fr) 1978-11-29 1979-11-23 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries

Country Status (26)

Country Link
US (1) US4284635A (fr)
EP (1) EP0013078A3 (fr)
JP (1) JPS5573657A (fr)
KR (1) KR830001214A (fr)
AR (1) AR224138A1 (fr)
AT (1) ATA750879A (fr)
AU (1) AU529136B2 (fr)
BE (1) BE880220A (fr)
CA (1) CA1121357A (fr)
DD (1) DD147537A5 (fr)
DK (1) DK504979A (fr)
EG (1) EG14137A (fr)
ES (2) ES486425A0 (fr)
FI (1) FI793663A (fr)
FR (2) FR2442836A1 (fr)
GB (1) GB2038812B (fr)
GR (1) GR72292B (fr)
HU (1) HU178532B (fr)
IL (1) IL58793A0 (fr)
IT (1) IT1126406B (fr)
LU (1) LU81923A1 (fr)
PH (1) PH15420A (fr)
PL (1) PL123672B1 (fr)
PT (1) PT70486A (fr)
SU (1) SU967275A3 (fr)
ZA (1) ZA796336B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212183A (en) * 1981-11-14 1993-05-18 Basf Aktiengesellschaft 4-(p-tert.-butylphenyl)-3-methylpiperidines substituted at the nitrogen, their quaternary salts and their use as fungicides
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
ZW10287A1 (en) * 1986-07-15 1988-01-13 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
EP0299549A3 (fr) * 1987-07-09 1989-02-08 Duphar International Research B.V 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates
CA1337418C (fr) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4piperidine(ou pyrrolidine ou hexahydroazepine) cardinols et leurs analogues heterocycliques
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3043845A (en) * 1958-12-29 1962-07-10 Abbott Lab Phenylmethylpiperidine derivatives
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
NL123743C (fr) * 1963-09-18
BE720927A (fr) * 1967-09-27 1969-03-03
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives
GB1403942A (en) * 1973-04-05 1975-08-28 Ciba Geigy Ag Piperidine derivatives
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
ZA777356B (en) * 1976-12-17 1979-01-31 Rohm & Haas Arthropod repellents

Also Published As

Publication number Publication date
US4284635A (en) 1981-08-18
PL123672B1 (en) 1982-11-30
PL219885A1 (fr) 1980-12-01
JPS5573657A (en) 1980-06-03
FR2453154A1 (fr) 1980-10-31
IL58793A0 (en) 1980-02-29
EG14137A (en) 1983-09-30
AU5310079A (en) 1980-05-29
PH15420A (en) 1983-01-07
FR2442836B1 (fr) 1983-07-29
EP0013078A2 (fr) 1980-07-09
IT7927614A0 (it) 1979-11-27
SU967275A3 (ru) 1982-10-15
ES8200664A1 (es) 1981-11-16
AU529136B2 (en) 1983-05-26
LU81923A1 (fr) 1980-04-22
EP0013078A3 (fr) 1980-10-01
PT70486A (en) 1979-12-01
HU178532B (en) 1982-05-28
GR72292B (fr) 1983-10-17
AR224138A1 (es) 1981-10-30
ES8101551A1 (es) 1980-12-16
DD147537A5 (de) 1981-04-08
CA1121357A (fr) 1982-04-06
DK504979A (da) 1980-05-30
GB2038812A (en) 1980-07-30
ES486425A0 (es) 1980-12-16
GB2038812B (en) 1983-01-06
ES493915A0 (es) 1981-11-16
ZA796336B (en) 1981-06-24
FR2453154B1 (fr) 1983-05-27
FI793663A (fi) 1980-05-30
FR2442836A1 (fr) 1980-06-27
IT1126406B (it) 1986-05-21
ATA750879A (de) 1983-03-15
KR830001214A (ko) 1983-04-29

Similar Documents

Publication Publication Date Title
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
BE879586A (fr) Phosphinylalcanoyl prolines, leur preparation et leur utilisation
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE868406A (fr) N'-phenyl-n-methyl-urees, leur preparation et leur emploi
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE886676A (fr) Pentapeptides homologues d'enkephalines, leur preparation et leur utilisation therapeutique
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE880182A (fr) Nouvelles azepino (1,2,3-1m)-beta-carbolines et leur preparation
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE880288A (fr) Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique